HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Robert L Coleman Selected Research
Robert L Coleman Research Topics
Disease
165
Ovarian Neoplasms (Ovarian Cancer)
12/2022 - 01/2002
163
Neoplasms (Cancer)
01/2022 - 01/2002
65
Carcinoma (Carcinomatosis)
04/2022 - 01/2002
40
Ovarian Epithelial Carcinoma
11/2021 - 01/2002
33
Endometrial Neoplasms (Endometrial Cancer)
04/2022 - 01/2007
20
Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 02/2002
16
Disease Progression
01/2021 - 07/2008
11
Neoplasm Metastasis (Metastasis)
01/2021 - 12/2006
9
Neutropenia
12/2022 - 04/2006
9
Anemia
12/2022 - 12/2010
9
Fatigue
01/2022 - 01/2008
8
Adenocarcinoma
01/2022 - 03/2004
8
Fallopian Tube Neoplasms
12/2021 - 12/2006
7
Nausea
01/2022 - 01/2008
7
Uterine Neoplasms (Uterine Cancer)
10/2021 - 05/2009
6
Hypertension (High Blood Pressure)
01/2022 - 11/2011
6
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 03/2002
5
Breast Neoplasms (Breast Cancer)
06/2020 - 03/2009
5
Hypoxia (Hypoxemia)
02/2018 - 11/2011
4
Sarcoma (Soft Tissue Sarcoma)
01/2021 - 01/2020
4
Vulvar Neoplasms (Vulvar Cancer)
04/2020 - 11/2012
4
Ascites
10/2016 - 01/2011
4
Pain (Aches)
07/2015 - 03/2002
3
Exanthema (Rash)
01/2022 - 04/2006
3
Vomiting
01/2021 - 01/2008
3
Granulosa Cell Tumor
04/2020 - 09/2009
3
Carcinosarcoma
01/2020 - 04/2011
3
Adenosquamous Carcinoma
01/2020 - 12/2007
3
Thrombocytopenia (Thrombopenia)
12/2019 - 05/2011
Drug/Important Bio-Agent (IBA)
64
Platinum
IBA
12/2022 - 01/2002
35
Paclitaxel (Taxol)
FDA Link
Generic
01/2022 - 01/2002
32
Poly(ADP-ribose) Polymerase Inhibitors
IBA
03/2022 - 06/2015
27
Biomarkers (Surrogate Marker)
IBA
01/2022 - 03/2004
26
Bevacizumab (Avastin)
FDA Link
05/2022 - 12/2007
22
rucaparib
IBA
12/2022 - 06/2016
22
Carboplatin (JM8)
FDA Link
Generic
01/2022 - 01/2002
22
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2021 - 08/2006
18
Pharmaceutical Preparations
IBA
12/2021 - 04/2006
17
taxane
IBA
11/2017 - 01/2002
16
Docetaxel (Taxotere)
FDA Link
01/2016 - 08/2006
15
Biological Products
IBA
01/2021 - 12/2007
14
liposomal doxorubicin (Doxil)
FDA Link
11/2021 - 08/2004
13
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
03/2022 - 07/2013
13
Topotecan (Hycamtin)
FDA Link
Generic
11/2020 - 01/2002
12
Small Interfering RNA (siRNA)
IBA
01/2022 - 08/2006
11
Proteins (Proteins, Gene)
FDA Link
01/2020 - 07/2008
10
olaparib
IBA
03/2022 - 11/2018
8
1-dodecylpyridoxal (PLD)
IBA
11/2021 - 10/2006
7
Monoclonal Antibodies
IBA
12/2021 - 09/2009
7
Progesterone Receptors (Progesterone Receptor)
IBA
04/2020 - 06/2009
7
Cisplatin (Platino)
FDA Link
Generic
01/2020 - 01/2002
6
Poly Adenosine Diphosphate Ribose
IBA
05/2022 - 01/2020
6
Estrogen Receptors
IBA
11/2020 - 07/2008
5
niraparib
IBA
03/2022 - 11/2018
5
Everolimus
FDA Link
01/2022 - 12/2010
5
trametinib
IBA
01/2022 - 01/2015
5
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2022 - 07/2015
5
Immunoconjugates (Immunoconjugate)
IBA
01/2022 - 09/2009
5
Letrozole (Femara)
FDA Link
Generic
01/2022 - 07/2008
5
veliparib
IBA
01/2022 - 06/2015
5
ErbB Receptors (EGF Receptor)
IBA
11/2020 - 01/2007
5
Angiogenesis Inhibitors
IBA
10/2020 - 12/2009
5
Taxoids (Taxanes)
IBA
01/2020 - 08/2006
5
Focal Adhesion Protein-Tyrosine Kinases
IBA
05/2019 - 08/2006
5
Gemcitabine
FDA Link
01/2017 - 03/2007
5
aflibercept
IBA
01/2016 - 04/2008
5
Ligands
IBA
01/2016 - 02/2007
5
Folic Acid (Vitamin M)
FDA Link
Generic
03/2015 - 06/2013
5
Proliferating Cell Nuclear Antigen (PCNA)
IBA
11/2011 - 09/2006
5
1,2-oleoylphosphatidylcholine (DOPC)
IBA
11/2011 - 08/2006
4
Peptides (Polypeptides)
IBA
01/2021 - 04/2014
4
DNA (Deoxyribonucleic Acid)
IBA
10/2020 - 12/2008
4
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
06/2016 - 01/2007
4
farletuzumab
IBA
03/2015 - 03/2010
4
Folate Receptor 1
IBA
01/2015 - 03/2010
3
MK 2206
IBA
04/2022 - 01/2020
3
tisotumab vedotin
IBA
01/2022 - 01/2020
3
FANG vaccine
IBA
12/2021 - 12/2020
3
Dasatinib (BMS 354825)
FDA Link
10/2021 - 04/2014
3
Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
IBA
01/2021 - 01/2014
3
Trabectedin
IBA
01/2021 - 01/2020
3
Hemoglobins (Hemoglobin)
IBA
01/2021 - 02/2013
3
Tyrosine Kinase Inhibitors
IBA
11/2020 - 07/2014
3
Hormones (Hormone)
IBA
04/2020 - 06/2009
3
Liposomes (Liposome)
IBA
05/2019 - 08/2006
3
Adrenergic Agents (Adrenergic Drugs)
IBA
01/2019 - 08/2006
Therapy/Procedure
137
Therapeutics
05/2022 - 01/2002
75
Drug Therapy (Chemotherapy)
12/2022 - 01/2002
14
Hysterectomy
10/2021 - 02/2002
13
Neoadjuvant Therapy
01/2022 - 03/2008
12
Lymph Node Excision (Lymph Node Dissection)
10/2021 - 02/2002
8
Cytoreduction Surgical Procedures
12/2021 - 10/2010
8
Immunotherapy
12/2021 - 01/2015
5
Combination Drug Therapy (Combination Chemotherapy)
04/2011 - 03/2007
4
Salpingo-oophorectomy
07/2020 - 03/2009
4
Laparotomy
01/2020 - 01/2007
4
Minimally Invasive Surgical Procedures
01/2020 - 10/2010
4
Drug Tapering
01/2019 - 04/2006
4
Radiotherapy
12/2010 - 01/2005
3
Aftercare (After-Treatment)
11/2020 - 01/2007